TABLE 4.
Patient | Sex | Pre surgery | 12 months post surgery | Remission prediction | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | T2D medication | Fasting plasma glucose | HbA1c | T2D medication | Fasting plasma glucose | HbA1c | Based on postsurgery data | Only clinical variables | Clinical and miRNAs | Only 10 miRNAs | Only 15 miRNAs | ||
A | F | 63 | Yes | 137 | NA | No | NA | 6.1 | Yes | No | No | No | No |
B | F | 41 | Yes | 118 | 6.4 | No | NA | 5.7 | Yes | Yes | Yes | Yes | No |
C | M | 43 | Yes | 127 | 6 | NA | 102 | 5.4 | Yes | Yes | No | No | No |
D | F | 49 | Yes | NA | 7.6 | No | NA | NA | Yes | No | Yes | Yes | Yes |
E | F | 54 | Yes | 135 | 7.5 | Yes | NA | 5.7 | No | No | No | No | No |
F | M | 37 | No | 110 | 6.6 | NA | 95 | 4.9 | Yes | Yes | Yes | No | No |
Abbreviations: F, female; HbA1c, hemoglobin A1c; LASSO, Least Absolute Shrinkage and Selection Operator; M, male; miRNA, microRNA; NA, not available; T2D, type 2 diabetes.